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     ABSTRACT 
BACKGROUND: 
To assess the quality of life in patients undergoing modified radical mastectomy 
for early breast cancer. 
MATERIALS & METHODS: 
This is a prospective study consisting of 50 patients who underwent modified 
radical mastectomy in our institution from 2013-2015 for early breast 
cancer.Patients above 60 years of age,all male breast cancer patients,patients 
with locally advanced disease,patients with metastatic disease and patients not 
consenting for this study were excluded.Quality of life was assessed 6 months 
after surgery  using a translated version of  a customised self designed 
questionnaire ,which is based on Royal college of surgeons questionnaire. 
RESULTS: 
In our study ,the most common age group among the cases were found to be 
between 51-60 years(24) age group and the least common age group being 30-
40 years(5) age group.Out of the 50 patients 47 patients(94%) did not have any 
restriction of daily activities and 3 patients (6%) had mild restriction of daily 
activities.Most of the patients(49) had mild pain and discomfort and 1 patient 
had severe pain.Among the patients experiencing mild pain 59%(29 patients) 
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had poor quality of life ,39%(19 patients) had average quality of life and 0nly 
2%(1 patient)had good quality of life.Most of the patients experiencing mild 
pain was in the 51-60 years age group (23),least in the 30-40 years age group(5) 
and the rest of the patients (21) in 41-50 years age group.Out of 50 patients 30 
had severe psychological impairment,15 had mild psychological impairment 
and 5 patients had no psychological impairment.Among the patients with severe 
psychological impairment 29 (97%) had poor quality of life and 1 (3%)had 
average quality of life.Most of the patients having severe psychological 
impairment  were under 51-60 years age (18),least in 30-40 years age (3) and 
the rest (9) in 41-50 years age group.Out of the 50 patients 34 were not satisfied 
in their body image perception,14 partially satisfied and 2 were completely 
satisfied in their body image perception.Among the patients with unsatisfied 
body image perception 30 (88%) had poor quality of life and 4(12%) had 
average quality of life.Most of the patients with unsatisfied body image 
perception were in 51-60 years age (22),least in 30-40 years age (3) and the rest 
in 41-50 years age (9). Out of the 50 patients 27 were not satisfied in their 
sexual life,18 were partially satisfied and 1 was completely satisfied in their 
sexual life,4 patients were not willing to disclose about their sexual life.Among 
the patients with unsatisfied sexual life 23 (85%) had poor quality of life and 4 
(15%) had average quality of life.Most of the patients with unsatisfied sexual 
life were in 51-60 years age (19),least in 30-40 years age (1) and the rest (7) in 
41-50 years age group.Out of the 50 patients 30 (60%)had poor quality of 
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life,19(38%) had average quality of life and 1 (2%) had good quality of 
life.Among the patients with poor quality of life 23 were from low 
socioeconomic status and 7 were from medium socioeconomic status,among 
patients with average quality of life 9 were from low socioeconomic status and 
10 from medium socioeconomic status and the 1 patient with good quality of 
life was from medium socioeconomic status.In the 30-40 years age group 3 had 
average quality of life and 4 had poor quality of life.In the 41-50 years age 
group 1 had good quality of life ,11 had average quality of life and 8 had poor 
quality of life.In the 51-60 years age group 5 had average quality of life and 18 
had poor quality of life. 
CONCLUSION: 
From this study we have concluded that the quality of life is poor in majority of 
the patients  undergoing modified radical mastectomy for early breast cancer 
with most of the patients having psychological impairment,unsatisfied body 
image perception ,unsatisfied sexual life and mild pain.In addition to these 
factors socioeconomic status of the patient also affects the quality of life in 
these patients. 
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           INTRODUCTION 
             
          Breast cancer is one of the leading causes of cancer in women all over 
India.Incidence statistics have been increasing over the last decades,for both 
premenopausal and postmenopausal women. Breast conservative surgery is the 
standard treatment for early breast cancer in the western world.On the other 
hand breast conservative surgery is not preferred in India.The reason for opting 
to modified radical mastectomy is concern about recurrence. 
 
             Although mortality rates in breast cancer are declining,many breast 
cancer survivors will experience physical and psychological sequelae that affect 
their everyday life.Few prospective studies have been done and little is known 
about the quality of life in this population. 
              
             The research on quality of life in breast cancer patients has been 
predominantly focused on the western world and has yielded mixed 
results.However there is paucity of quality of life data in  Indian patients.Due to 
the increasing incidence of breast cancer in Indian population ,it is imperative to 
look into the quality of life experienced by  our patients after treatment.  
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              The assessment  of quality of life after modified radical mastectomy for 
early breast cancer  patients using a translated customised self designed 
questionnaire have shown that majority of the patients experience poor quality 
of life. 
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AIMS AND OBJECTIVES 
 
To assess the quality of life after modified radical mastectomy in 
early breast cancer patients using a translated customised  self 
designed questionnaire.  
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      REVIEW OF LITERATURE 
HISTORY OF BREAST CANCER 
The history of breast cancer dates back to  377 B.C where Hippocrates made 
references to breast cancer and provided detailed descriptions about its effects. 
In 525 B.C. Democedes successfully treated a woman with breast disease. 
In 1600 B.C. where Ebers Papyrus suggested diagnosis and treatment of breast 
tumor by heat cauterisation using fire drills and excision by knife. 
In 1714 A.D.,Petit Published Traite des Operations, that explained the roots of 
cancer lie in enlarged lymphatic nodes and advocated removing lymph nodes, 
pectoral fascia along with some muscle fibers. 
In 1786 Cruikshank described lymphatics of the human breast. 
In 1845 cooper described the suspensory ligaments. 
From 1882 -1907 Halsted extensively worked out on the procedure known as 
the radical mastectomy. 
In 1885 Sappey noted the presence of subareolar plexus of lymphatics . 
In 1896 Tansini performed immediate breast reconstruction  by using latissimus 
dorsi musculocutaneous flap after a  radical mastectomy. 
In 1897 Gocht irradiated inoperable breast cancer patients. 
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In 1899 Rotter noted that tumor metastasizes along the lymphatics of the breast 
to the inter pectoral nodes. 
In 1943 Patey and Dyson  developed modified radical mastectomy  
In 1952 Urban performed removal of the enlarged intraplueral parasternal nodes 
following radical mastectomy. 
In 1974 Olivari used lattismus dorsi myocutaneous flap. 
In 1976 Olivari placed silicone prosthesis under the flap. 
In 1981 Veronessi published the first study stating that survival rates for breast 
conservation procedures  equals to that of radical mastectomy. 
EMBRYOLOGY OF BREAST: 
The breast is a group of  glands derived from epidermis. It lies in a network of 
fascia ,which is derived from the dermis and  from the superficial fascia of the 
anterior surface of the thorax. The nipple is a localised  proliferation of the 
stratum spinosum  layer of the epidermis. 
During eight weeks of gestation, two bands of thickened ectoderm appear on the 
anterior body wall extending from  the axilla to  the groin. These bands are  
called the milk lines and represent future  mammary gland tissue . Only the 
pectoral portion of these bands will remain and ultimately develops  into adult 
mammary gland. Occasionally  breast tissue can arise from other portions of the 
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milk line. The glandular portion of the breast develops from ectoderm,as it 
arises from a local thickening of  epidermis . From this thickening, sixteen to 
twenty four  buds of ectodermal cells grow into underlying mesoderm (dermis) 
during the third month of gestation. The buds are solid at first and  become 
canalized near term to form lactiferous ducts . The tips of the bud  gives  rise to  
secretory acini during  the period of lactation. The surface of the developing  
nipple is a shallow pit at first and by full term  it becomes everted . The areola 
becomes  visible from the fifth month  of gestation onward. An inverted nipple 
can be a developmental arrest rather than a  disease. 
Eventhough  minor changes are  occuring during each menstrual cycle, 
pregnancy and lactation brings  about the ultimate development of  breasts. 
Progesterone, prolactin, and placental lactogen are key hormones that stimulates 
the formation of secretory alveoli ,that develops at the end of the branched 
ducts. With continued development, the cells in the secretory alveoli acquire 
increasing number of  organelles which are  related to protein synthesis and 
milk  secretion. 
During the period of  lactation, prolactin  hormone from  anterior pituitary gland 
causes the  mammary glands to secrete milk proteins and lipids. Milk ejection 
occurs  as a  response to  neural impulses caused  by sucking  at the breast. This 
stimulation  causes the  release of  the hormone oxytocin by the paraventricular 
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nuclei of hypothalamus via  posterior pituitary gland. These  impulses also 
inhibits the release of luteinizing hormone.  
When nursing is stopped,the prolactin secretion is reduced. There is regression 
of  alveoli and the duct system to the nonpregnant state. 
 
 
 
This picture depicts the milk line(mammary line). 
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ANATOMY OF BREAST: 
The adult female breast lies within the superficial fascia of the anterior chest 
wall. The breast  extends from  second rib above to  sixth or seventh rib below, 
and medially from the sternal border  to  midaxillary line laterally.Majority of 
the base of  breast lies over  the pectoralis major muscle and a minor portion  
lies over the serratus anterior muscle. A small part lies over the external oblique 
aponuerosis. 
 The tail (of Spence)  is a prolongation of breast tissue of the upper lateral 
quadrant towards the axilla entering through  a hiatus (of Langer) located  in the 
deep fascia of  medial axillary wall, the only portion of  breast tissue found  
beneath the deep fascia.  
The epidermis of the areola and the nipple is pink in color due to blood vessels 
that lie close to the surface in long dermal papillae . In females there is  increase 
in  melanin content of the basal cell during puberty and during each pregnancy 
thereby darkening the area . The dermis  merges with  superficial fascia, that 
envelops the parenchyma of  breast. 
The superficial fascia  that envelops the breast continues with the superficial 
fascia of the abdomen( Camper) below, and with  the superficial part of the 
cervical  fascia above and  merges with the dermis of the skin anteriorly. 
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The pectoral fascia envelops the pectoralis major and continues with the deep  
fascia of the abdomen  below. It attaches medially  to sternum and to  clavicle 
superiorly and axillary fascia  laterally. The anterior lamina unites with the 
pectoralis minor fascia near the lateral border of the pectoralis major muscle and 
to the serratus fascia inferiorly. The suspensory ligament of the axilla is the 
posterior extension continuing with the latissimus dorsi fascia . 
The clavipectoral fascia envelops the pectoralis minor muscle and subclavius  to 
attach to the clavicle ,dividing into anterior and posterior lamina between the 
subclavius muscle. The extent of the clavipectoral fascia is  between  axillary 
fascia,  clavicle, and coracoid process,uniting laterally with anterior lamina of 
pectoralis major fascia. 
 The costocoracoid membrane, a part of  clavipectoral fascia is pierced by  
cephalic vein,  thoracoacromial vessels, lymphatics  and a branch of the lateral 
pectoral nerve . 
The axilla is a pyramidal space with an apex, a base, anterior,posterior,medial 
and lateral walls. The apex is triangular in shape bordered by clavicle,  scapula, 
and first rib,also called the cervicoaxillary canal. The base contains the axillary 
fascia beneath the skin . The anterior wall is composed of   pectoralis major,  
pectoralis minor, subclavius  and the clavipectoral fascia.The posterior wall 
consists of scapula, subscapularis, latissimus dorsi, and  teres major .The medial 
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wall is formed by  lateral chest wall, second to sixth ribs, and serratus anterior . 
The lateral wall is formed by  bicipital groove of humerus . 
 
This picture depicts  axilla and the vessels.  
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This picture demonstrates the location of the breast in the superficial fascia . 
26 
 
ARTERIAL SUPPLY: 
The breast derives its blood supply from  internal thoracic artery, branches of  
axillary artery, and  intercostal arteries,with considerable amount of  variation. 
The internal thoracic artery(internal mammary),a branch of subclavian artery 
supplies the majority of the blood to breast. Perforating branches from  the 
internal thoracic artery supply the medial half of  breast and the surrounding 
skin.  
Four branches fom the  axillary artery supplies the breast. They are the superior 
thoracic branch,  pectoral branches of  thoracoacromial artery,  lateral thoracic 
arteries, and  unnamed branches. The lateral thoracic artery is the most 
important  vessel among these branches. The axillary vessels and its branches 
supplies the lateral aspect of the breast. 
The lateral half of  breast  is  also supplied by  branches from  third, fourth, and 
fifth intercostal arteries.  Only the branches of  internal thoracic artery are 
constantly present. There are anastomoses between the three vessels  supplying 
the breast. 
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This picture depicts  the blood supply to breast,chest and axilla.  
Venous Drainage 
The venous drainage is by axillary, internal thoracic, and  third to fifth 
intercostal veins and they follow the arteries. 
The axillary vein  formed by union of  basilic with brachial veins  and it 
receives  pectoral branches draining from the breast. At  the outer border of  
first rib, it  becomes the subclavian vein. 
The intercostal veins partly drains  posteriorly to the vertebral venous system, 
and anteriorly, they drain to the internal thoracic veins. 
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 Medial drainage through internal thoracic vein to the right heart. Posterior 
drainage to vertebral veins.  Lateral drainage to intercostal, superior epigastric 
veins, and liver. Lateral superior drainage through axillary vein to the right 
heart.  
LYMPHATIC DRAINAGE: 
Lymphatics  from the breast drain into inconstant groups of nodes of varying 
numbers. 
Group 1. External mammary nodes or the anterior pectoral nodes,located along 
the lateral border of  pectoralis minor, along  the course of  lateral thoracic 
artery  receives lymph from lateral and medial trunks that drain the upper and 
lower half of the breast respectively. 
Group 2. Scapular nodes located over the subscapular vessels and their 
thoracodorsal branches,and they communicate with the intercostal lymphatics. 
Group 3. Central nodes, the largest group of nodes located  in the center of  
axilla. 
Group 4. Interpectoral nodes (Rotter's nodes) . They are located between the 
pectoralis major and minor muscles.. 
Group 5. Axillary vein nodes,that lie over  the caudal and ventral surfaces  of 
axillary vein. 
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Group 6. Subclavicular nodes  
Lymphatics from the medial edge of  breast  reach the internal thoracic nodes 
along the course of perforating vessels. The internal thoracic trunks receives 
lymphatics from opposite breast  and drain into  thoracic duct or  right side  
lymphatic duct.  
 
This picture depicts the lymphatic drainage of the breast 
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This picture depicts the various levels of lymph nodes. 
NERVE SUPPLY: 
The nerves arise from the second to sixth  intercostal nerves, with mammary 
branches passing over  the surface of the gland . 
PHYSIOLOGY OF BREAST: 
There are around  twenty individual compound alveolar glands present  in each 
breast,with independent opening in the surface of the nipple. 
31 
 
At puberty, the breasts enlarge due to increased fat deposition between the lobes 
and lobules,with prominence of nipple and a minor development of the duct 
system. The  secretory structures develops  in response to pregnancy. 
Estrogen affects breast development  and progesterone (during 
pregnancy)affects the development of secretory alveoli. Prolactin and chorionic 
somatomammotrophin causes the final development of  secretory alveoli.  
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This picture depicts the breast at various physiologic stages. 
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Lactation  
 With pregnancy, the duct system completes its development.The secretory 
phase is influenced  by  progesterone, lactogenic hormones (maternal and 
placental), and estrogen.  
Milk Ejection 
Milk ejection occurs only during nursing. The sucking stimulation sends 
sensory impulses to the hypothalamus that stimulates oxytocin secretion by 
paraventricular nuclei , and  also inhibits the release of PIH(prolactin inhibiting 
hormone). Oxytocin stimulates myoepithelial cells  causing milk ejection. 
Regression of Breast Tissue 
During regression the  alveoli disappear and lobules reduce in size.Connective 
tissue  partitions become thicker. 
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CARCINOMA BREAST: 
EPIDEMIOLOGY: 
Carcinoma breast is one of the most common cancer diagnosed  and one of the 
most common cause of cancer related mortality.The life time risk of developing 
cancer breast is approximately 1 in 8% to 1 in 12% and the risk of death from 
the disease in a persons lifetime is approximately 2.4%(20).The increased rate 
of detection and increase in survival rates are due to the contribution of 
screening mammography and improvement in systemic adjuvant therapy.In 
India breast is the second most common cancer in females.Rapid 
industrialisation in developing countries have contributed to the increasing 
incidence of carcinoma breast.  
RISK FACTORS: 
Multiple risk factors have been associated with carcinoma breast and the 
following table( 19)summarises the category at risk and the relative risk for 
each of them. 
 
 
Risk Factor Category at Risk 
Relative 
Risk 
Germline mutations BRCA-1 and < 40 years old 
BRCA-1 and 60 to 69 years old 
200 
15 
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Proliferative breast disease Lobular carcinoma in situ 
Ductal carcinoma in situ 
16.4 
17.3 
Personal history of breast cancer Invasive breast cancer 6.8 
Ionizing radiation exposure Hodgkin disease 5.2 
Family history 1
st
 degree relative with 
premenopausal breast cancer 
First-degree relative with 
postmenopausal breast cancer    1.8     
3.3 
 
Age at first childbirth 
Hormone replacement therapy 
with estrogen and progesterone 
Older than 30 years 
Current user for at least 5 years 
1.7-1.9 
1.3 
Early menarche Younger than 12 years 1.3 
Late menopause Older than 55 years 1.2-1.5 
 
PERSONAL FACTORS: 
Age, gender and personal or family history of carcinoma breast are the most 
significant personal risk factors ,with gender being the most important risk 
factor with a female to male ratio of 100:1.There is a rapid increase in the 
incidence after 4
th
 decade, and an increased incidence with a slower rate after 
menopause.There is a 1.5-3 fold increase in risk of developing the disease in 
persons with an affected first degree relative. 
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GENETIC FACTORS: 
Only five to ten percent of breast cancer  results from inherited gene mutation. 
The following table(18) illustrates the incidence of breast cancer. 
Sporadic breast cancer 65%–75% 
Familial breast cancer 20%–30% 
Hereditary breast cancer 5%–10% 
BRCA1a 45% 
BRCA2 35% 
p53a (Li-Fraumeni syndrome) 1% 
STK11/LKB1a (Peutz-Jeghers syndrome) <1% 
PTENa (Cowden disease) <1% 
MSH2/MLH1a (Muir-Torre syndrome) <1% 
ATMa (Ataxia-telangiectasia) <1% 
Unknown 20% 
aAffected gene. 
The following table(23) illustrates the autosomal dominant conditions 
associated with possible development of breast cancer 
 
Syndrome Defect 
Associated Condition or Increased 
Risk 
BRCA-1 Mutation of chromosome 17q Malignancies of the breast, ovaries, 
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and possibly prostate and colon 
BRCA-2 Mutation of chromosome 13q Malignancies of the breast 
(including male), ovaries, prostate, 
larynx, and pancreas 
Li-
Fraumeni 
Mutation in the p53 gene on 
chromosome 17p 
Malignancies of the breast, brain, 
and adrenal glands; soft-tissue 
sarcomas 
Muir-
Torre 
Mutation in DNA mismatch 
repair genes (hMLH1 and 
hMSH2) on chromosome 2p 
Malignancies of the breast and 
gastrointestinal (GI) and 
genitourinary tracts; sebaceous 
tumors (i.e., hyperplasia, adenoma, 
epithelioma, carcinoma), 
keratoacanthoma 
Cowden 
disease 
Mutation in the PTEN gene on 
chromosome 10q 
Malignancies of the breast, colon, 
uterus, thyroid, lung, and bladder; 
hamartomatous polyps in GI tract 
Peutz-
Jeghers 
Mutation in the STK11 gene on 
chromosome 19p 
Malignancies of the breast and 
pancreas; mucocutaneous melanin 
deposition, hamartomas of the GI 
tract 
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PATHOLOGY: 
Invasive breast  carcinomas are found  to be histologically heterogeneous and 
majority of them are adenocarcinomas arising from  terminal ducts. The  
common five  histologic variants of  adenocarcinoma are; 
 Infiltrating ductal carcinoma:This type of tumor  accounts for most of the 
breast cancers (75%). The absence of specific  histologic features is the 
characteristic feature of this type of tumor. On palpation this feels hard  
and gritty on  transection.There is varying degree of fibrotic reaction. 
There can be associated  DCIS within the specimen. This type of tumor  
commonly metastasize to axillary lymph nodes. The  overall prognosis of 
this type is poorer than other histologic subtypes. Distant metastases to 
bones, lungs, liver, and brain are found. 
 Infiltrating lobular carcinoma: This type of tumor  is seen in five to ten 
percent of breast cancer patients. Clinically, areas  of ill-defined 
thickening  are present within the breast. Arrangement of small cells in a 
single or Indian file pattern are hallmark microscopic findings of this 
type. They have a  tendency  to grow around the  ducts and  the lobules. 
They are more frequently multicentric and often bilateral than compared 
to infiltrating ductal carcinoma.The prognosis is similar to that of 
infiltrating ductal carcinoma. In addition to axillary nodal metastasis, this 
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type  metastasize to unusual sites  for example  meninges and serosal 
surfaces, more often than any other pathological forms . 
 Tubular carcinoma:This type of tumor  accounts for only 2% of breast 
carcinomas. The diagnosis is made if there is >75% of the tumor shows  
tubule formation. Axillary nodal metastases are uncommon in this type. 
The prognosis  is  better than that for other types. 
 Medullary carcinoma :This type of tumor accounts for five  to seven 
percent of breast cancers.Poor differentiation  nuclei, a syncytial growth 
pattern,circumscribed border, lymphocyte and plasma cell intense 
infiltration, and little or no DCIS are the characteristic histological 
features of this type of tumor. The prognosis is favorable; however,there 
can be  mixed variants with invasive ductal components  and they have 
prognoses similar to that of  invasive ductal carcinoma. 
 Mucinous or colloid carcinoma:This type of tumor  constitutes 
approximately three percent  of breast cancers. Accumulation of abundant 
extracellular mucin surrounding tumor cluster is the characteristic feature 
of this type. They are bulky and slow growing tumors with a favourable 
prognosis. 
The following are rare histologic types of  carcinoma breast  - papillary, 
apocrine, secretory, squamous ,  spindle cell  and carcinosarcoma. Infiltrating 
ductal carcinomas  can be mixed with these special histologic subtypes 
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occasionally. Tumors with  mixed histology behave similarl to pure infiltrating 
ductal carcinomas. 
The following are some of the histologic pictures of infiltrating ductal and 
infiltrating lobular carcinoma. 
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Invasive lobular carcinoma showing the Indian file pattern. 
CLINICAL FEATURES: 
Physical examination  must  give due consideration to  comfort and emotions of 
the patient. Careful inspection with  patient sitting upright. Nipple changes, 
gross asymmetry, and visible  masses are  noted. The skin is inspected for  
dimpling ,  puckering and peau d'orange.Always the inframammary fold 
,periclavicular regions should be inspected .Both axillae are then  palpated. If 
palpable  nodes are found their number, size, and mobility should be noted and 
axillary tail should also be palpated . 
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The following picture depicts the inspection of breast. 
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The following picture depicts the palpation of breast. 
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The following picture shows peau de orange appearance 
 
DAIGNOSTIC IMAGING: 
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The choice of diagnostic imaging  should be customised  for individual  patient . 
It depends  on the age and charecteristics of the cancer. 
MAMMOGRAPHY: 
It is the initial step of evaluation.Mammography  assess the malignant potential 
of palpable lesion and for screening for  non palpable lesions. The presence of 
stellate or spiculated appearance in mammogram is classical of malignancy. 
Calcifications, nipple changes, and lymphadenopathy in axilla can be visualised.  
The positive predictive value  for  these mammographic findings  is 70% to 
80%.The accuracy of  mammography is least in patients with dense breast and 
hence not accurate for screening in younger patients less than 30 years of age. 
  
The above mammogram shows spiculation and microcalcifications. 
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Mammographic signs of malignancy are microcalcifications and density 
changes. Microcalcifications can be clustered or scattered. Density changes are  
discrete masses, architectural distortions, and asymmetries.Spiculated masses 
when  associated  with architectural distortion, and clustered  
microcalcifications  either in linear or branching array, or  microcalcifications 
intermingled  with a mass are the most predictive findings of mammography 
suggestive of malignancy. The American College of Radiology  has developed 
BIRADS, Breast Imaging Reporting and Data System, that categorizes 
mammographic findings into the  following: I = negative (no evidence of 
malignancy); II = benign ; III = probably benign; IV = findings suspicious for 
malignancy ( IVa, mildly and IVb, moderately suspicious); and V = highly 
suspicious for malignancy (more than ninety percent  chance of malignancy). 
Once  mammography detects a suspicious lesion, further workup  is necessary 
for diagnosis. For findings  interpreted as BIRADS 3,counseling and repeat 
mammogram in 6 months to  be done in patients at low risk for malignancy 
ULTRASONOGRAM: 
Ultrasound is of particular use in younger patients with denser breast where 
interpretation of mammogram is difficult, and to differentiate solid from cystic 
lesions.It is also used for localisation of impalpable areas of breast pathology.As 
it is operator dependent it cannot be used as a screening tool.It is being 
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increasingly used for guided percutaneous biopsy of suspicious glands in the 
axilla. 
 
This is an ultrasound picture of carcinoma of breast. 
MAGNETIC RESONANCE IMAGING: 
The following are the indications for MRI in carcinoma breast  
1.To distinguish scar from recurrence in patients previously treated with 
BCS(breast conservation surgery),less accurate in lessthan 9 months of 
radiotherapy 
2.In lobular carcinoma to assess the multicentricity and multifocality,and in 
DCIS to assess the extent 
3.The imaging modality of choice for breast with implants. 
4.Screening tool in high risk patients  
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a.documented BRCA 1or BRCA 2 mutation 
b.1
st
 degree relative with BRCA1 or 2 mutation,who were not previously 
genetically tested 
c.history of mantle radiation 
d.history of breast cancer syndromes. 
  
BREAST BIOPSY TECHNIQUES: 
 Mammographic evaluation of mass with suspicious of malignancy to be 
followed  by fineneedle aspiration (FNA) biopsy or a core-needle biopsy 
preferably.Biopsy is deferred before mammogram is completed  as  needle-
puncture hematoma will obscure the  radiographic features. Needle biopsy with 
or without image guidance is the preferred  mode of evaluation for younger 
women with dense breast  as mammogram is not the ideal modality. 
FNAC: 
The following are the advantages-rapid,painless,inexpensive.No incision prior 
to selection of local therapy.The disadvantages are does not distinguish invasive 
from insitu cancer.Markers are not routinely available(ER,PR,HER 2).False 
negative results and insufficient specimen occur. 
CORE NEEDLE BIOPSY: 
The following are the advantages- rapid,painless,inexpensive.No 
incision,markers  are routinely available and can be read by any pathologist.The 
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disadvantages are-false negative results and incomplete lesion characterisation 
can occur. 
EXCISIONAL BIOPSY: 
The following advantages are –false negative results are rare,complete histology 
is available before treatment decisions,may serve as a definitive 
lumpectomy.The disadvantages are expensive ,painful,creates an incision to be 
incorporated in definitive surgery,unnecessary surgery with potential for 
cosmetic deformity in patients with benign abnormalities. 
INDICATIONS FOR SURGICAL BIOPSY AFTER CORE NEEDLE 
BIOPSY: 
1.Failure to sample calcifications 
2.diagnosis of atypical ductal hyperplasia 
3.diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ 
4.radial scars 
5.papillary lesions 
6.lack of concordance between imaging and histological findings 
 
TRIPLE ASSESSMENT: 
In patients presenting with lump in breast or symptoms and signs highly 
suspicious of malignancy ,a diagnosis has to be made based on the combination 
of clinical examination,radiological findings and histopathological findings 
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known as the triple assessment.This combination has a positive predictive value 
of more than 99.9 percent. 
 
STAGING: 
Current AJCC TNM classification and stage grouping for breast 
carcinoma 
Classification 
and Stage 
Grouping Definition 
Primary tumor (T) 
TX Primary tumor cannot be assessed 
T0 No evidence of primary tumor 
Tis Carcinoma in situ 
   Tis (DCIS) Ductal carcinoma in situ 
   Tis (LCIS) Lobular carcinoma in situ 
   Tis (Paget) Paget disease of the nipple with no tumor 
T1 Tumor 2 cm or less in greatest dimension 
   T1mic Microinvasion 0.1 cm or less in greatest dimension 
   T1a Tumor more than 0.1 cm but not more than 0.5 cm in greatest 
dimension 
   T1b Tumor more than 0.5 cm but not more than 1 cm in greatest 
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dimension 
   T1c Tumor more than 1 cm but not more than 2 cm in greatest 
dimension 
T2 Tumor more than 2 cm but not more than 5 cm in greatest 
dimension 
T3 Tumor more than 5 cm in greatest dimension 
T4 Tumor of any size with direct extension to 
a. chest wall or  
b. skin, only as described as follows 
   T4a Extension to chest wall, not including pectoralis muscle 
   T4b Edema (including peau d'orange) or ulceration of the skin of 
the breast, or satellite skin nodules confined to the same 
breast 
   T4c Both T4a and T4b 
   T4d Inflammatory carcinoma 
Regional lymph nodes (N) 
NX Regional lymph nodes cannot be assessed (e.g., previously 
removed) 
N0 No regional lymph node metastasis 
N1 Metastasis in movable ipsilateral axillary lymph node(s) 
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N2 Metastases in ipsilateral axillary lymph nodes fixed or matted, 
or in clinically apparent ipsilateral internal mammary nodes 
in the absence of clinically evident axillary lymph node 
metastasis 
   N2a Metastasis in ipsilateral axillary lymph nodes fixed to one 
another (matted) or to other structures 
   N2b Metastasis only in clinically apparent ipsilateral internal 
mammary nodes and in the absence of clinically evident 
axillary lymph node metastasis 
N3 Metastasis in ipsilateral infraclavicular lymph node(s), or in 
clinically apparent ipsilateral internal mammary lymph 
node(s) and in the presence of clinically evident axillary 
lymph node metastasis; or metastasis in ipsilateral 
supraclavicular lymph node(s) with or without axillary or 
internal mammary lymph node involvement 
   N3a Metastasis in ipsilateral infraclavicular lymph node(s) and 
axillary lymph node(s) 
   N3b Metastasis in ipsilateral internal mammary lymph node(s) and 
axillary lymph node(s) 
   N3c Metastasis in ipsilateral supraclavicular lymph node(s) 
Regional lymph 
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nodes (pN) 
pNX Regional lymph nodes cannot be assessed (e.g., previously 
removed, not removed for pathological study) 
pN0 No regional lymph node metastasis histologically, no 
additional examination for isolated tumor cells 
   pN0(i-) No regional lymph node metastasis histologically, negative 
IHC 
   pN0(i+) No regional lymph node metastasis histologically, positive 
IHC, no IHC cluster greater than 0.2 mm 
   pN0(mol-) No regional lymph node metastasis histologically, negative 
molecular findings (RT-PCR) 
   pN0(mol+) No regional lymph node metastasis histologically, positive 
molecular findings (RT-PCR) 
pN1mi Micrometastasis (greater than 0.2 mm, none greater than 2.0 
mm) 
pN1 Metastasis in 1 to 3 axillary lymph nodes, and/or in internal 
mammary nodes with microscopic disease detected by 
sentinel lymph node dissection but not clinically apparent 
   pN1a Metastasis in 1 to 3 axillary lymph nodes 
   pN1b Metastasis in internal mammary nodes with microscopic 
disease detected by sentinel lymph node dissection but not 
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clinically apparent 
   pN1c Metastasis in 1 to 3 axillary lymph nodes and in internal 
mammary lymph nodes with microscopic disease detected by 
sentinel lymph node dissection but not clinically apparent 
pN2 Metastasis in 4 to 9 axillary lymph nodes, or in clinically 
apparent internal mammary lymph nodes in the absence of 
axillary lymph node metastasis 
   pN2a Metastasis in 4 to 9 axillary lymph nodes (at least one tumor 
deposit greater than 2.0 mm) 
   pN2b Metastasis in clinically apparent internal mammary lymph 
nodes in the absence of axillary lymph node metastasis 
pN3 Metastasis in 10 or more axillary lymph nodes, or in 
infraclavicular lymph nodes, or in clinically apparent 
ipsilateral internal mammary lymph nodes in the presence of 
1 or more positive axillary lymph nodes; or in more than 3 
axillary lymph nodes with clinically negative microscopic 
metastasis in internal mammary lymph nodes; or in ipsilateral 
supraclavicular lymph nodes 
   pN3a Metastasis in 10 or more axillary lymph nodes (at least one 
tumor deposit greater than 2.0 mm), or metastasis to the 
infraclavicular lymph nodes 
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   pN3b Metastasis in clinically apparent ipsilateral internal mammary 
lymph nodes in the presence of 1 or more positive axillary 
lymph nodes; or in more than 3 axillary lymph nodes and in 
internal mammary lymph nodes with microscopic disease 
detected by sentinel lymph node dissection but not clinically 
apparent 
   pN3c Metastasis in ipsilateral supraclavicular lymph nodes 
Distant metastasis (M) 
MX Distant metastasis cannot be assessed 
M0 No distant metastasis 
M1 Distant metastasis 
 
STAGE GROUPING: 
TNM STAGE GROUPING 
Stage 0 Tis N0 M0 
Stage IA T1a N0 M0 
Stage IB T0 N1mi M0 
                T1a N1mi M0 
Stage IIA T0 N1b M0 
                  T1a N1b M0 
                  T2 N0 M0 
Stage IIB T2 N1 M0 
                  T3 N0 M0 
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Stage IIIA T0 N2 M0 
                   T1a N2 M0 
                   T2 N2 M0 
                   T3 N1 M0  
                   T3 N2 M0 
Stage IIIB T4 N0 M0 
                   T4 N1 M0 
                   T4 N2 M0 
Stage IIIC Any T N3 M0 
Stage IV Any T Any N M1 
The following pictures show the T and N staging. 
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PRETREATMENT EVALUATION: 
 Appropriate treatment strategy  involves  accurate evaluation of the extent of 
disease  locally in the breast and in the  regional nodes and in the distant sites ( 
lung, liver, and bone). For patients with early  breast cancer, a complete history 
and physical examination, a plain  radiograph of the chest, and serum liver 
chemistries is usually adequate.In asymptomatic  patients with apparently early 
breast carcinoma  the routine use of bone scans has an extremely low yield  and 
hence not routinely recommended. Liver imaging is indicated  in the 
preoperative evaluation of patients with early breast cancer  only when there is 
increased liver enzymes or a palpable hepatomegaly. 
Ultrasound is used  to evaluate  axillary nodal basin and any suspicious 
lymphadenopathy. Suspicious nodes are sampled by image -guided FNA.   
Positive axillary nodes  are planned for  axillary lymph node dissection   during 
lumpectomy or mastectomy, or can be subjected to  systemic neoadjuvant 
chemotherapy. 
TREATMENT: 
Early-Stage Breast Cancer (T1, T2, N0, N1) 
 Patients with early breast cancer are generally treated either with breast 
conservation surgery and radiation therapy or total mastectomy with or without 
breast  reconstruction and the  regional nodes are evaluated  in the form axillary 
lymph node dissection or sentinel lymph node biopsy. 
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BREAST CONSERVATION VERSUS MASTECTOMY 
Patients with carcinoma  breast  can be  treated effectively  with breast-
conserving surgery(BCS). Several  prospective randomized trials have  
compared  breast conservation surgery  with  mastectomy either radical or 
modified radical ,and there is no survival benefit to the more aggressive 
approach.  The Milan trial that  was limited to early breast cancer showed  no  
statistically significant differences in local  disease control,DFS( disease-free 
survival), or OS (overall survival) rate have been noted.The same results have 
been noted  even in the recent follow-up.(17) 
NSABP B-06 examined patients with primary tumor up to four cm  and N0 or 
N1 nodal disease. Patients were randomly assigned to MRM or lumpectomy 
with axillary lymph node dissection, or lumpectomy and axillary lymph node 
dissection with radiation therapy. Disease-free and overall survival rates were 
the same among the three groups, but  local disease  recurrence rate was 
significantly  reduced at 10 years with addition of  radiation therapy (12% with 
RT vs. 53% without RT). These results upheld  that breast conservation surgery  
as an appropriate treatment modality  for patients with early breast cancer and  
radiation should be  an integral part of any breast conservation strategy. 
 The systemic therapy is  based on age of the patient , size of the tumor, lymph  
nodal involvement, and  hormone receptor status and can be  given before 
(neoadjuvant) or after (adjuvant) surgery. Radiation therapy is begun three  to 
four  weeks following  surgery.  
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The use of partial breast irradiation  for breast conservation instead of whole 
breast irradiation with a boost dose to tumor site is currently under  
investigation. Advantages  are shorter  duration of  treatment (5 days vs. 6 
weeks); less scattering of  radiation to nearby structures  and less skin  
complications. Partial breast irradiation is still experimental and  to be 
performed under protocol only. The delivery methods can be intraoperatively 
through brachytherapy catheters or postoperative 3 D conformal radiation.  
 Summary of selected NSABP therapeutic trials for invasive breast cancer 
Trial Treatment Outcome 
NSABP 
B-04 
Total mastectomy vs. total 
mastectomy with XRT vs. radical 
mastectomy 
No significant difference in 
disease-free or overall survival 
rates 
NSABP 
B-06 
Total mastectomy vs. lumpectomy 
vs. lumpectomy with XRT 
No significant difference in 
disease-free or overall survival 
rates; addition of XRT to 
lumpectomy reduced local 
recurrence rate from 39% to 10% 
NSABP 
B-13 
Surgery alone vs. surgery plus 
adjuvant chemotherapy in node-
negative patients with estrogen 
receptor-negative tumors 
Improved disease-free survival 
rate for adjuvant chemotherapy 
group 
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NSABP 
B-14 
Surgery alone vs. surgery plus 
adjuvant tamoxifen in node-negative 
patients with estrogen receptor-
positive tumors 
Improved disease-free survival 
rate for adjuvant tamoxifen group 
NSABP 
B-18 
Neoadjuvant chemotherapy with 
doxorubicin, cyclophosphamide, or 
both for 4 cycles vs. the same 
regimen given postoperatively 
No significant difference in 
overall survival or disease-free 
survival rates (53% and 70% at 9 
years in the postoperative group 
and 69% and 55% in the 
preoperative group) 
NSABP 
B-21 
Lumpectomy plus tamoxifen vs. 
lumpectomy plus tamoxifen plus 
XRT vs. lumpectomy plus XRT for 
node-negative tumors <1 cm 
Combination of XRT and 
tamoxifen was more effective 
than either alone in reducing 
ipsilateral breast tumor 
recurrence 
NSABP 
B-27 
Neoadjuvant chemotherapy 
comparing AC Ã— 4 cycles then 
surgery vs. AC Ã— 4 cycles, 
docetaxel Ã— 4 cycles then surgery 
vs. surgery between 4 cycles of AC 
and 4 cycles of docetaxel 
Groups I and III were combined 
and compared with group II; 
clinical and pathological 
complete response rates 
increased significantly among 
patients who received 
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preoperative AC and docetaxel 
NSABP 
B-32 
SLN biopsy followed by axillary 
dissection vs. SLN biopsy alone for 
clinically node-negative patients 
SLN identification rate was 
similar in both groups, accuracy 
was high for both, negative 
predictive value was high for 
both 
 
Although breast conservation therapy  and mastectomy are equivalent in  
survival rates for early breast cancer , the decision for breast conservation has to 
be  made individually. The success of BCT depends on  the  motivation and 
commitment  of the patient. Most important is long-term follow-up  to detect  
recurrence.For patients with small breasts and a sizeable tumor, the cosmetic 
result is usually  unacceptable following local excision of the tumor.For patients 
with  large or pendulous breasts, there is  lack of uniformity in  dosing of 
radiation and hence  results in  fibrosis and retraction. Patients usually benefit 
from mastectomy  with reconstruction and  surgical augmentation or reduction 
of the opposite  breast. 
Absolute and relative contraindications to BCT(16) 
Absolute contraindications 
Prior radiotherapy to the breast or chest wall 
Radiotherapy use during pregnancy 
Diffuse suspicious or malignant-appearing microcalcifications 
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Multicentric disease 
Positive pathologial margin after multiple attempts to obtain negative margins 
Relative contraindications 
Multifocal disease requiring two or more separate surgical incisions 
Active connective tissue disease involving the skin (especially scleroderma and 
lupus) 
Tumor size >5 cm (controversial) 
Focally positive margins after multiple attempts to obtain negative margins 
 
Although, there is no significant  difference in overall survival rate between  
mastectomy or BCT for early breast carcinoma, there is a  difference in 
recurrence rates. There is  no  statistically significant difference in the local 
recurrence rate  by histology of the tumor. The following factors have been 
associated with increased  risk of local recurrence: patients less than thirty five  
years and  tumors more  than two , irrespective of the nodal  status. For patients 
with nodal disease , nuclear grade of the tumor correlates   significantly  
with recurrence. The local recurrence rates for breast conservation  ranges from 
2.6% to 18%, a slightly higher  rate than the range  for mastectomy (2.3% to 
13%). (15) . The ultimate goal of breast conservation  for patients with early 
breast carcinoma is provision of   cosmetic result without oncological 
compromise. Multidisciplinary effort combined with good patient selection is of 
utmost importance to the success of breast conservation. 
Axillary Lymph Node Dissection 
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ALND is  gold standard treatment for lymph node metastases,for staging and 
local control and has a minor contribution for the overall survival of the patient 
and gives prognostic information.Its routine use  has been redefined  by the 
development of sentinel lymph node  biopsy technique. Nevertheless, it  is still 
considered as the 1
st
  line of management  for local disease  control and staging , 
in situations such as  biopsy-proven axillary  nodal metastases and  suspicious 
or palpable axillary node. 
The incidence of axillary nodal metastases increases with the increase in  the 
primary tumor size.Patients with apparent early breast carcinoma can  present 
with axillary  lymph node metastases.Micrometastasis (< 2 mm diameter)  has a 
better prognosis than macrometastasis. 
The current standard of care is axillary lymph node dissection of anatomic level 
one and level two node in all patients with early breast cancer. Patients with 
undergoing  breast conservation surgery for early breast cancer axillary 
dissection and en bloc removal of level one and level two nodes(preserving long 
thoracic & thoracodorsal nerves &axillary vein) and level three(only if grossly 
or pathologically involved) should be performed through a separate incision in 
the axilla without extending to the anterior pectoral fold.Removal of clinically 
negative level three  nodes is of no  benefit &has an elevated risk of 
lymphedema.Patients with early breast cancer with  low risk of axillary  nodal 
involvement donot require a full axillary dissection, & sentinel lymph node  
biopsy can be a better way to stage the axillary involvement..  
71 
 
Sentinel Lymph Node Biopsy 
The complications  associated with the  use of axillary dissection to determine 
axillary metastases has questioned its use in a select group of patients. Most  
studies state that  SLN detection has  an accuracy of 97% to 100%, with a false-
negative rate of 0% to 10%.(24) 
This  can be done with  radiolabeled colloid, vital blue dye, or both.. A 
handheld gamma counter, aids in the visualisation intraoperatively to locate the 
sentinel node. 
SLN biopsy may not useful in the following conditions: palpable axillary nodes, 
medially  located   tumor and  preoperative lymphoscintigraphy has  not 
identified the sentinel node,  past surgery in  axilla, and  more than 6 cm  biopsy 
cavity .  
MODIFIED RADICAL MASTECTOMY: 
Mastectomy along with removal of nodal tissues of axilla with preservation of 
muscular contours of upper chest wall. The operation is modified from  classic 
radical mastectomy to improve  the cosmetic outcome  without oncological 
compromise. The steps are: 
Position the patient  with arm extended out; may drape arm free if desired. 
Incise an ellipse of skin with  nipple-areolar complex and the  skin over tumor 
Develop flaps at the fusion plane between subcutaneous fatty tissue and 
fatty envelop of breast  upto  lateral border of sternum medially, clavicle 
superiorly, rectus sheath  inferiorly, latissimus dosi muscle   laterally. 
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Elevate  the breast tissue  from  underlying pectoralis major muscle from 
superomedial to inferolateral direction. 
Take  the pectoral fascia  along with the specimen for cancer. 
Leave the  breast tissue  attached at lateral aspect and the weight of breast is 
used  to facilitate retraction. 
The  pectoral fascia is incised  at the  lateral edge of pectoralis major and 
elevate the muscle. 
Dissection is continued  under the  pectoralis major muscle, with  removal of  
all fibrofatty node bearing tissue. 
The  median pectoral nerve is preserved. 
The fibrofatty tissue laterally  is swept gently to expose the  long thoracic nerve 
and the nerve is protected with an umblical tape. 
The axillary vein is identified and preserved  and the  fibrofatty tissue is swept 
downwards. 
The  thoracodorsal vein is identified and ligated with  preservation of 
thoracodorsal nerve and artery. 
All fatty tissue is swept  downwards and  dissection is terminated. 
Hemostasis and lymph stasis is achieved  and  wound closed over two closed 
suction drains. 
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The above picture shows patient position and skin incision. 
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The above picture show the development of flaps. 
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The above picture shows removal of breast tissue from pectoralis major. 
 
The above picture shows axillary vein identification and initial dissection. 
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The above picture shows identification and preservation of nerves. 
BREAST RECONSTRUCTION: 
For patients undergoing mastectomy , breast reconstruction has to  be 
considered a standard option . Reconstruction can be with  autologous tissue, 
synthetic implants, or both.There is psychological benefit and better 
cosmesis,without delay in adjuvant chemotherapy with immediate 
reconstruction . Patients requiring  postmastectomy radiation, are counselled to 
delay reconstruction.  
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 The most frequently used faps are pedicled or free transverse rectus abdominis 
myocutaneous flaps. Contralateral augmentation or reduction can be performed 
to attain symmetry.Skin-sparing mastectomy  provides  a natural contour to the 
reconstructed breast. There is no significant  increased risk of local recurrence 
with skin-sparing mastectomy. 
SYSTEMIC THEPAPY IN EARLY BREAST CANCER: 
Adjuvant chemotherapy  is considered in the following conditions:for patients 
with  axillary node-positive disease, tumor size greater than 1 cm, and patients 
with node-negative disease  of  size  more than 0.5 cm with adverse prognostic 
features (lymphovascular invasion,increased nuclear and histologic 
grade,hormone receptor negative disease,overexpression or amplification of 
HER-2/neu. 
 Adjuvant endocrine therapy is considered for patients with ER,PR positive 
cancers(hormone receptor-positive) ,and with the recommendation of  an 
aromatase inhibitor in postmenopausal patient. There is some controversy as to 
whether patients to recieve 5 years of an aromatase inhibitor or 2 
years of tamoxifen followed by aromatase inhibitor for  3 years also known as 
the switch regimen .There is more preference 5 years  treatment with an  
aromatase inhibitor, for patients with elevated risk of recurrence.  Trastuzumab 
is a  HER-2/neu–targeted drug and is the only agent approved for use therapy  in  
adjuvant setting.As per  the BCIRG 006 study reported  concurrent 
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administration of  trastuzumab  with docetaxel and carboplatin is  as effective as 
giving trastuzumab following chemotherapy.(25,26) 
QUALITY OF LIFE AFTER MODIFIED RADICAL MASTECTOMY: 
Due to the advancement in technology there is an increase in the  rate of early 
detection and increased survival  of patients and hence bringing the issue of 
quality of life  in patients with longer life expectancy(13). 
After the post treatment phase patients experience problems in physical,social 
and psychological aspects that ultimately determine the decline in qol(12). 
Loss of breast tissue is of paramount importance for   female sexuality  as it 
affects the sexuality ,body image perception and reproductivity  and disrupts the 
psycho social balance thereby affecting the quality of life(14). 
In a study of 100 patients with breast cancer who underwent surgical 
intervention (either BCS or MRM) irrespective of chemotherapy or 
radiotherapy have concluded that BCS had a better quality of life than MRM in 
terms of better body image,sexual function,physical emotional and social 
functioning(11). 
Studies have shown that improvement in qol have shown increased motivation 
for screening of breast cancer(10). 
In a study by pockaj and his colleagues they found that  evaluation of qol after a 
long term follow up is more validated than after shorter follow up(9)(8)(7). 
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      MATERIALS AND METHODS 
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PLACE OF STUDY 
 Department  of  General  surgery-  Stanley medical college  & hospital  . 
DURATION 
     2013 to  2015 
STUDY DESIGN 
     Prospective study 
PATIENT SELECTION 
    All patients undergoing modified radical mastectomy for early breast cancer. 
EXCLUSION CRITERIA 
      1.Patients with locally advanced breast cancer 
      2.Patients with metastatic breast disease 
      3.patients above 60 years of age 
      4.Patients with male breast cancer 
      5.Patients not consenting for the study 
 SAMPLE SIZE         50   
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              QUESTIONNAIRE 
DAILY ACTIVITIES 
1.I need help preparing meals-yes/no 
2.I need help doing laundry-yes/no 
3.I need help washing myself and dressing myself-yes/no 
PSYCHOLOGICAL ASPECT 
1.Confident in a social setting-none/most of the time 
2.Emotionaly healthy-none/most of  the time 
3.Accepting of your body-none/most of the time  
PAIN 
1.Shoulder/arm pain-none/most of the time 
2.Difficulty lifting/moving your arms-none/most of the time 
3.Sleep disturbance due to breast discomfort-none/most of the time 
4.Swelling  of arm on the side of surgery-none/most of the time 
BODY IMAGE 
1.How do I look in the mirror clothed-satisfied/dissatisfied 
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2.  How do I look in the mirror unclothed-satisfied/dissatisfied 
SEXUAL LIFE 
1.Sexualy attractive in your clothes-none/most of the time 
2.Sexualy attractive when unclothed-none/most of the time 
3.Satisfied with your sexual life-none/most of the time 
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     RESULTS 
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The age distribution of patients with early breast cancer in our study is 
shown.The maximum number of patients are in the age group of 51-60 years 
with the least number in the 30-40 years age group. 
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In our study patients with scores 6 and less were considered as having poor 
quality of life,scores 7 to 11 as average quality of life and scores 12-15 as good 
quality of life.As per this study 60%(30 )patients have poor quality of 
life,38%(19)patients have average quality of life and 2%(1)patients have good 
quality of life.  
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In our study only one patient had good quality of life and that patient comes 
under 41-50 years of age . 
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This chart age distribution of the patients with average quality of life,with 
maximum number of patients with average quality of life(11) are under 41-50 
years age group and the least(3) in 30-40 years age group. 
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In our study the number of patients with poor quality of life in 30-40 years,41-
50 years,51-60 Years are 4 ,8 and 18 respectively 
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In this study 1 patient with good quality of life was from medium 
socioeconomic status. 
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In our study 47%(9)patients with average quality of life were from low 
socioeconomic status,53%(10)patients were from medium socioeconomic 
status,with none from high socioeconomic status.   
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In our study 77%(23)patients with poor quality of life were from low 
socioeconomic status,23%(7)patients with poor quality of life were from 
medium socioeconomic status,with none from high socioeconomic status 
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This table shows the no of patients having restriction in daily activities. In our 
study 47 patients had no restriction of daily activities and 3 patients had mild 
restriction of daily activities.Patients who had scored 1 and 2 in this section in 
the questionnaire are considered to have mild restriction,scores 0 and 3 are 
considered to have severe and no restriction of daily activities  respectively 
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In our study patients who scored 0 and 1 in this section of the questionnaire 
were considered to have severe and mild psychological impairment 
respectively.Patients who scored 2 had no impairment.In our study maximum 
number of patients have severe psychological impairment(30 patients).The 
number of patients with no and mild impairment  are 5 and 15 respectively. 
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In our study maximum number of patients with severe psychological 
impairment are under 51-60 years of age(18 patients).The  number of patients 
with severe psychological impairment  under 30-40 years and 41-50 years are 3 
and 9 patients respectively. 
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This pie chart relates the patients with severe psychological impairment with 
their quality of life.In our study 97%(29 patients)with severe psychological 
impairment have poor quality of life and 3%(1 pt)with severe psychological 
impairment have average quality of life with none of the patients having good 
quality of life. 
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In our study patients who scored 0 and 1 in this section in the questionnaire 
were considered having severe pain,scores 2 and 3were considered as having 
mild pain and score 4 were considered as having no pain.In this study 49 
patients had mild pain and only one patient had severe pain. 
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In our study  the number of patients experiencing mild pain in 51-60 years of 
age is 23,in 41-50 years of age is 21 and 30-40 years of age is 5. 
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This pie chart relates the patients with mild pain with their quality of life.In our 
study 59%(29 ) of patients with mild pain have poor quality of life,39%(19) 0f 
patients with average quality of life and 2%(1)patients have good quality of life. 
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In this study patients with scores2,1 and 0 in this section of the questionnaire 
were considered to be satisfied ,partially satisfied and not satisfied in body 
image perception respectively.Maximum number of patients (34) were not 
satisfied,14 patients were partially satisfied and 2 patients were completely 
satisfied in body image perception  as per our study. 
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In our study number of patients with poor body image perception under 51-60 
years is 22 ,under 41-50 years is9 and under 30-40 years is 3. 
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This pie chart relates the patients who were not satisfied in their body image 
perception with their respective quality of life.In our study 88%(30) of patients 
who were not satisfied in their body image perception have poor quality of life 
and  12%(4)of patients have average quality of life with none having good 
quality of life. 
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Patients with scores 3,1 and 2,0 in this section of the questionnaire were 
considered satisfied,partially satisfied and not satisfied in their sexual life 
respectively.Maximum number of patients(27) were not satisfied,the number of 
patients who were partially and completely satisfied in their sexual life were 18 
and 1 respectively.4 patients were not willing to disclose about their sexual life. 
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In our study the number of patients who were not satisfied in sexual life under 
51-60 years,41-50 years,30-40 years are 19 ,7 and 1 respectively,with maximum 
number of patients in 51-60 years of age. 
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This pie chart relates the patients who were not satisfied in their sexual life with 
their respective quality of life.85%(23)of patients who were not satisfied in their 
sexual life have poor quality of life and 15%(4)of patients who were not 
satisfied in their sexual life  have average quality of life with none of the 
patients having good quality of life. 
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DISCUSSION: 
In our study almost all the patients were from underprivileged section of 
the society.As per the age distribution of the disease and the quality of life ,in 
this study 80% of the patients under 40 years of age have poor quality of life 
and 75% of the patients between 51-60 years had poor quality of life.This has 
been supported by a study by park and his colleagues(6).Most of the studies 
have shown that younger patients experience more problem  with respect to 
their partner relationship,sexual function and body image perception. 
Majority of the patients were from low socioeconomic status and of the 
patients from low SE status 72% were having poor quality of life.Among the 
patients from medium socioeconomic status 56% were having average quality 
of life and 39% were having poor qol.This has been supported by Chinese study 
by fang et al(5) and a Korean study.Patients from higher socioeconomic status 
have better access to health care and higher resources and have better coping up 
skills and these explain the fact mentioned above. 
In our study most of the patients(94%) have no restriction  of daily 
activities and only six percent have mild restriction of daily activities.Most of 
the patients (98%) experience some form of mild pain and discomfort.As per 
the studies by Beaulac(4) and colleagues  pain and physical function of 
outcomes of modified radical mastectomy  is related to the use of axillary 
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dissection. The daily activities have been mostly related to the premorbid 
condition of the patient rather than the effect of treatment. 
In our study majority of the patients(68%) were not satisfied in their body 
image perception.Among these patients 91% were more than 51 years of age 
and 88% had poor quality of life.Body image is often thought of just relating to 
physical appearance alone but studies have related them to functionality and 
sense of fullness(27).The impact of disturbed body image perception includes 
altered sexual function ,loss of libido and relationship problems(28). 
In this study majority of the patients(60%) had severe psychological 
impairment and 30% had mild psychological impairment.Among the patients 
with severe psychological impairment almost all of the patients had poor quality 
of life .Among the various age groups 75% of the patients were above 51 years 
of age.The psychological changes associated with aging and menopause also  
contribute to the psychological state after surgery.Studies have shown that 
psychological impairment improves with time(3) and since we had a follow up 
of only 6 months this improvement has not been found in this study.  
  In this study more than half(54%) of the patients were not satisfied with 
their sexual life  and 36% were partially satisfied in their sexual life.Among the 
patients not satisfied in sexual life majority of them had poor quality of life 
.Most of the patients above 51 years were not satisfied in their sexual life.Due to 
the traditional cultural factors refusal to reply to questions regarding their sexual 
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life was  8% as expected and most of them were above 51 years of age.The 
disturbed body image perception also  contributes to the disturbance in sexual 
life.The sexual function is also affected by adjuvant treatment and menopausal 
status with post menopausal women more affected. 
  The overall quality of life is poor in 60% of the patients ,average in 
38% of the patients and good in only 2% of the patients.  
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CONCLUSION: 
From this study we have concluded that the quality of life at the end of six 
months after modified radical mastectomy in majority of the patients with early 
breast cancer is poor.The quality of life is affected in the following 
domains,namely daily activities,pain,body image perception,sexual life and 
psychological impairment. 
The age of the patient , socioeconomic status of the patient, the comorbid 
conditions and the need for adjuvant treatment also affects the quality of life. 
As most of the studies show no significant difference in the oncological 
outcomes between BCS and MRM, and there is  superior cosmesis and 
improved quality of life with breast conservation surgery,BCS can be tried in a 
select group of patients in our setting.However long term results are equivocal. 
As majority of quality of life data are based on western literature there is 
increasing need of this in our own patients due to the increased incidence  and 
early detection of the disease. 
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                                                             PROFORMA 
Name:  
 
Age: 
 
IP .NO:  
 
Socio-economic status: 
 
Address: 
 
Occupation: 
 
Education: 
 
Marital status: 
 
Menopausal status: 
 
Date of surgery: 
 
Date of discharge: 
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                                                            CONSENT                                                                                                                                                                         
Name:       Age:          IP: 
 
I herewith declare that I have been explained in a language fully understood by me regarding the 
purpose of this study, methodology, proposed intervention, plausible side effects, if any and sequelae. 
I have been given an opportunity to discuss my doubts and I have received the appropriate 
explanation. 
I understand that my participation in this study is completely voluntary and that I am free to withdraw 
from this study at anytime without any prior notice &/ or without having my medical or legal rights 
affected. 
I permit the author and the research team full access to all my records at any point, even if I have 
withdrawn from the study. However my identity will not be revealed to any third party or publication. 
I herewith permit the author and the research team to use the results and conclusions arising from this 
study for any academic purpose, including but not limited to dissertation/ thesis or publication or 
presentation in any level. 
Therefore, in my full conscience, I give consent to be included in the study and to undergo any 
investigation or any intervention therein. 
 
 
   Patient’s Sign        Investigator’s Sign 
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